Biotech

LessDeath is planning for a post-aging future

Biotech

Juvenescence and Buck Institute launch company to target heart disease

Biotech

Preclinical study demonstrates long-term success of allogeneic islet implantation for diabetes

Co-implantation of allogeneic islets and streptavidin-presenting microgels provided excellent glycaemic control.
Biotech

Plug-and-play organ-on-a-chip can be customised patient-by-patient

Biotech

Startup boasts multiple novel compounds with potential to halt progress of age-related disease

Biotech

Genflow Biosciences moves into cellular reprogramming

Biotech

Small but mighty – how nanobodies are fighting chronic inflammation

Biotech

New lab grown miniature heart that can beat by itself

Biotech

YouthBio CEO: The time is right to develop epigenetic reprogramming therapies

Biotech

Strategic collaboration set to develop an iPSC-derived cell therapy platform

Biotech

Japan university tackles aging with transplanted pluripotent stem cells

Biotech

MitoRx Therapeutics lands funding to target mitochondrial dysfunction and age-related disease

Biotech

Juvenescence and Buck Institute set the (ke)tone for metabolism and ketosis research

Biotech

James Peyer: Geroscience evidence is the key to unlocking preventative therapies

Biotech

BioAge announces first cohort dosed in Phase 1b clinical trial of muscle aging therapy

Biotech

Active ingredient in Juvenescence’s Metabolic Switch induces ketosis, new study finds

Biotech

Low-dose lithium could slow kidney aging, new research finds

Biotech

YouthBio Therapeutics: New epigenetic rejuvenation startup emerges from stealth

Biotech

James Peyer on breaking the geroscience dam

Biotech

Andrew Steele: Our goal must be to cure aging

Biotech

We need a better understanding of senescence to build better senolytics

Biotech

SENISCA – targeted interventions that boast exquisite specificity

Biotech

Research reverses aging in human skin cells by 30 years

Biotech

Serpin therapy has fibrosis in its sights with clinical trial slated for 2023

Biotech

Swiss scientists crack muscle recovery, repairing age-related fatigue

Biotech

Fauna Bio partners with UW Oshkosh in search for novel therapies for disease

Biotech

Focus on frailty: New senolytic holds potential for sarcopenia treatment

Biotech

Rejuvenate Biomed starts groundbreaking sarcopenia trial with eye on future growth

Biotech

Insilico identifies therapeutic targets implicated in aging using AI and hallmarks of aging framework

Biotech

Genflow collaborates with Aging Research Centre to drive sirtuin research

Biotech

Strategic partnership plans disruptive, personalised AI engine to counter skin aging

Biotech

Is gene therapy ready to take flight?

Biotech